Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen

The Clostridium perfringens epsilon toxin, a select agent, is responsible for a severe, often fatal enterotoxemia characterized by edema in the heart, lungs, kidney, and brain. The toxin is believed to be an oligomeric pore-forming toxin. Currently, there is no effective therapy for countering the c...

Full description

Bibliographic Details
Main Authors: Mark S. McClain, Michelle Lewis, Charles David Weaver
Format: Article
Language:English
Published: MDPI AG 2010-07-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/2/7/1825/
_version_ 1811300874056630272
author Mark S. McClain
Michelle Lewis
Charles David Weaver
author_facet Mark S. McClain
Michelle Lewis
Charles David Weaver
author_sort Mark S. McClain
collection DOAJ
description The Clostridium perfringens epsilon toxin, a select agent, is responsible for a severe, often fatal enterotoxemia characterized by edema in the heart, lungs, kidney, and brain. The toxin is believed to be an oligomeric pore-forming toxin. Currently, there is no effective therapy for countering the cytotoxic activity of the toxin in exposed individuals. Using a robust cell-based high-throughput screening (HTS) assay, we screened a 151,616-compound library for the ability to inhibit e-toxin-induced cytotoxicity. Survival of MDCK cells exposed to the toxin was assessed by addition of resazurin to detect metabolic activity in surviving cells. The hit rate for this screen was 0.6%. Following a secondary screen of each hit in triplicate and assays to eliminate false positives, we focused on three structurally-distinct compounds: an N-cycloalkylbenzamide, a furo[2,3-b]quinoline, and a 6H-anthra[1,9-cd]isoxazol. None of the three compounds appeared to inhibit toxin binding to cells or the ability of the toxin to form oligomeric complexes. Additional assays demonstrated that two of the inhibitory compounds inhibited ε-toxin-induced permeabilization of MDCK cells to propidium iodide. Furthermore, the two compounds exhibited inhibitory effects on cells pre-treated with toxin. Structural analogs of one of the inhibitors identified through the high-throughput screen were analyzed and provided initial structure-activity data. These compounds should serve as the basis for further structure-activity refinement that may lead to the development of effective anti-ε-toxin therapeutics.
first_indexed 2024-04-13T06:58:57Z
format Article
id doaj.art-71cc955b3b824d2fabbac42202be110d
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-13T06:58:57Z
publishDate 2010-07-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-71cc955b3b824d2fabbac42202be110d2022-12-22T02:57:10ZengMDPI AGToxins2072-66512010-07-01271825184710.3390/toxins2071825Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput ScreenMark S. McClainMichelle LewisCharles David WeaverThe Clostridium perfringens epsilon toxin, a select agent, is responsible for a severe, often fatal enterotoxemia characterized by edema in the heart, lungs, kidney, and brain. The toxin is believed to be an oligomeric pore-forming toxin. Currently, there is no effective therapy for countering the cytotoxic activity of the toxin in exposed individuals. Using a robust cell-based high-throughput screening (HTS) assay, we screened a 151,616-compound library for the ability to inhibit e-toxin-induced cytotoxicity. Survival of MDCK cells exposed to the toxin was assessed by addition of resazurin to detect metabolic activity in surviving cells. The hit rate for this screen was 0.6%. Following a secondary screen of each hit in triplicate and assays to eliminate false positives, we focused on three structurally-distinct compounds: an N-cycloalkylbenzamide, a furo[2,3-b]quinoline, and a 6H-anthra[1,9-cd]isoxazol. None of the three compounds appeared to inhibit toxin binding to cells or the ability of the toxin to form oligomeric complexes. Additional assays demonstrated that two of the inhibitory compounds inhibited ε-toxin-induced permeabilization of MDCK cells to propidium iodide. Furthermore, the two compounds exhibited inhibitory effects on cells pre-treated with toxin. Structural analogs of one of the inhibitors identified through the high-throughput screen were analyzed and provided initial structure-activity data. These compounds should serve as the basis for further structure-activity refinement that may lead to the development of effective anti-ε-toxin therapeutics.http://www.mdpi.com/2072-6651/2/7/1825/bacterial toxinsClostridium perfringenscell membrane permeabilitysmall molecule librariesstructure-activity relationshipdrug evaluationpreclinical
spellingShingle Mark S. McClain
Michelle Lewis
Charles David Weaver
Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen
Toxins
bacterial toxins
Clostridium perfringens
cell membrane permeability
small molecule libraries
structure-activity relationship
drug evaluation
preclinical
title Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen
title_full Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen
title_fullStr Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen
title_full_unstemmed Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen
title_short Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen
title_sort identification of small molecule inhibitors of clostridium perfringens ε toxin cytotoxicity using a cell based high throughput screen
topic bacterial toxins
Clostridium perfringens
cell membrane permeability
small molecule libraries
structure-activity relationship
drug evaluation
preclinical
url http://www.mdpi.com/2072-6651/2/7/1825/
work_keys_str_mv AT marksmcclain identificationofsmallmoleculeinhibitorsofclostridiumperfringensetoxincytotoxicityusingacellbasedhighthroughputscreen
AT michellelewis identificationofsmallmoleculeinhibitorsofclostridiumperfringensetoxincytotoxicityusingacellbasedhighthroughputscreen
AT charlesdavidweaver identificationofsmallmoleculeinhibitorsofclostridiumperfringensetoxincytotoxicityusingacellbasedhighthroughputscreen